Corrigendum to: Experience of patients with metastatic breast cancer in France: results of the 2021 RÉALITÉS survey and comparison with 2015 results
-
Jean-Sébastien Frenel
,
Séverine Guiu
Corrigendum to: Frenel, Jean-Sébastien, Guiu, Séverine, Guéroult-Accolas, Laure, Zernik, Nicole, Lefeuvre-Plesse, Claudia and Moley-Massol, Isabelle. “Experience of patients with metastatic breast cancer in France: results of the 2021 RÉALITÉS survey and comparison with 2015 results” Oncologie, vol. 25, no. 3, 2023, pp. 211–221. https://doi.org/10.1515/oncologie-2022-1018.
The authors regret to inform you that we noticed an error in our recently published paper “Experience of patients with metastatic breast cancer in France: results of the 2021 RÉALITÉS survey and comparison with 2015 results” Oncologie, vol. 25, no. 3, 2023, pp. 211–221. https://doi.org/10.1515/oncologie-2022-1018.
In the Result part, section “Current or past treatments”, paragraph 4, instead of “ In all treatments combined, fatigue remained the most reported AE (82 % of patients in 2015 and 2020–2021), particularly in patients coming from a university/regional hospital centre (94.7 %, p<0.001), followed by nausea, hair loss, pain and skin dryness for 48 , 46, 43 and 41 % of 2020–2021 responders, respectively (Figure 2)”, the correct sentence is “In all treatments combined, fatigue remained the most reported AE (82 %), particularly in patients coming from a university/regional hospital centre (94.7 %, p<0.001), followed by nausea, hair loss, pain and skin dryness for 48 , 46, 43 and 41 % of 2020–2021 responders, respectively ( Figure 2 )”. This change has been made following an error in Figure 2 which displayed the frequencies of adverse events experienced by patients in the Réalités 1 (2015) study as the frequencies in Réalités 2. Figure 2 has been updated with the correct data for the Réalités 1 (2015) study (see corrected Figure 2). Although this display error has no impact on the analyses carried out in the article, we wanted to have this information printed as an erratum.
Adverse events (AE) experienced and impact on patient daily lives.
© 2023 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- Review Article
- Ethosomes as delivery system for treatment of melanoma: a mini-review
- Research Articles
- Pre-treatment predictors of cardiac dose exposure in left-sided breast cancer radiotherapy patients after breast conserving surgery
- Glycoprofiling of early non-small cell lung cancer using lectin microarray technology
- Overexpression of TRIM28 predicts an unfavorable prognosis and promotes the proliferation and migration of hepatocellular carcinoma
- MiRNA-219a-1-3p inhibits the malignant progression of gastric cancer and is regulated by DNA methylation
- The effect of ubiquitin-specific peptidase 21 on proliferation, migration, and invasion in DU145 cells
- Automatic prediction model of overall survival in prostate cancer patients with bone metastasis using deep neural networks
- Clinical neutrophil-related gene helps treat bladder urothelial carcinoma
- Forkhead Box P4 promotes the proliferation of cells in colorectal adenocarcinoma
- Effect of a CrossMab cotargeting CD20 and HLA-DR in non-Hodgkin lymphoma
- Case Reports
- Endoscopic resection of gastric glomus tumor: a case report and literature review
- Long bone metastases of renal cell carcinoma imaging features: case report and literature review
- The Warthin-like variant of papillary thyroid carcinomas: a clinicopathologic analysis report of two cases
- Corrigendum
- Corrigendum to: Experience of patients with metastatic breast cancer in France: results of the 2021 RÉALITÉS survey and comparison with 2015 results
Articles in the same Issue
- Frontmatter
- Review Article
- Ethosomes as delivery system for treatment of melanoma: a mini-review
- Research Articles
- Pre-treatment predictors of cardiac dose exposure in left-sided breast cancer radiotherapy patients after breast conserving surgery
- Glycoprofiling of early non-small cell lung cancer using lectin microarray technology
- Overexpression of TRIM28 predicts an unfavorable prognosis and promotes the proliferation and migration of hepatocellular carcinoma
- MiRNA-219a-1-3p inhibits the malignant progression of gastric cancer and is regulated by DNA methylation
- The effect of ubiquitin-specific peptidase 21 on proliferation, migration, and invasion in DU145 cells
- Automatic prediction model of overall survival in prostate cancer patients with bone metastasis using deep neural networks
- Clinical neutrophil-related gene helps treat bladder urothelial carcinoma
- Forkhead Box P4 promotes the proliferation of cells in colorectal adenocarcinoma
- Effect of a CrossMab cotargeting CD20 and HLA-DR in non-Hodgkin lymphoma
- Case Reports
- Endoscopic resection of gastric glomus tumor: a case report and literature review
- Long bone metastases of renal cell carcinoma imaging features: case report and literature review
- The Warthin-like variant of papillary thyroid carcinomas: a clinicopathologic analysis report of two cases
- Corrigendum
- Corrigendum to: Experience of patients with metastatic breast cancer in France: results of the 2021 RÉALITÉS survey and comparison with 2015 results
